Indeed, we found that bsAb-mediated cross-linkage of non-activated T cells via the co-receptor CD8 is not sufficient to trigger T effector cell functions but the combination of pre-activation and co-ligation leads to an efficient and selective tumor cell killing. The gene discussed is CD8A; the disease is neoplasm.